Coya Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of proprietary therapies to enhance the function of regulatory T cells (Tregs). Its candidate product pipeline is based on therapeutic modalities, s...
Leadership
Arun Swaminathan Ph.D.
CEO & Director
Fred Grossman D.O., FAPA
President & Chief Medical Officer
David S. Snyder M.B.A.
CFO & COO
Aaron Thome Ph.D.
Head of Neuroinflammation Platform
Michelle Frazier Ph.D.
Senior Vice President of Regulatory
Karen King M.S.
Senior VP of Program Management & Clinical Operations
